menu search

JAN / JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference

JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference
Chief Medical Officer Dr. Amol Soin will discuss innovative approaches to pain management and JanOne's development of non-addicting treatments for pain LAS VEGAS , Aug. 31, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, will participate in investor sessions at the H.C. Wainwright 25 th  Annual Global Investment Conference in New York City. Read More
Posted: Aug 31 2023, 13:30
Author Name: PRNewsWire
Views: 102254

JAN News  

JanOne to Present at the Dawson James 8th Annual Investment Conference

By PRNewsWire
September 21, 2023

JanOne to Present at the Dawson James 8th Annual Investment Conference

Chief Medical Officer Dr. Amol Soin will explain innovative approaches to pain management and JanOne's development of non-addicting treatments for pai more_horizontal

JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference

By PRNewsWire
August 31, 2023

JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference

Chief Medical Officer Dr. Amol Soin will discuss innovative approaches to pain management and JanOne's development of non-addicting treatments for pai more_horizontal

JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting

By PRNewsWire
August 18, 2023

JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting

JAN101 Showed Statistically Significant Reduction in Pain and Improvement in Nerve Conduction Velocity in Prior Phase II study. LAS VEGAS , Aug. 18, 2 more_horizontal


Search within

Pages Search Results: